Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Glucagon receptor | ||
Ligand | BDBM50244339 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_491826 (CHEMBL945216) | ||
IC50 | 160±n/a nM | ||
Citation | Kim, RM; Chang, J; Lins, AR; Brady, E; Candelore, MR; Dallas-Yang, Q; Ding, V; Dragovic, J; Iliff, S; Jiang, G; Mock, S; Qureshi, S; Saperstein, R; Szalkowski, D; Tamvakopoulos, C; Tota, L; Wright, M; Yang, X; Tata, JR; Chapman, K; Zhang, BB; Parmee, ER Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett18:3701-5 (2008) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Glucagon receptor | |||
Name: | Glucagon receptor | ||
Synonyms: | GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR) | ||
Type: | Enzyme | ||
Mol. Mass.: | 54026.92 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P47871 | ||
Residue: | 477 | ||
Sequence: |
| ||
BDBM50244339 | |||
n/a | |||
Name | BDBM50244339 | ||
Synonyms: | CHEMBL469904 | trans-N-((1H-tetrazol-5-yl)methyl)-4-(((4-tert-butylcyclohexyl)(1-methyl-1H-benzo[d]imidazol-2-yl)amino)methyl)benzamide | ||
Type | Small organic molecule | ||
Emp. Form. | C28H36N8O | ||
Mol. Mass. | 500.6384 | ||
SMILES | Cn1c(nc2ccccc12)N(Cc1ccc(cc1)C(=O)NCc1nnn[nH]1)[C@H]1CC[C@@H](CC1)C(C)(C)C |r,wU:27.30,wD:30.37,(-6.06,-.47,;-5.29,.86,;-3.86,1.45,;-3.99,2.99,;-5.49,3.34,;-6.22,4.69,;-7.76,4.73,;-8.56,3.41,;-7.82,2.06,;-6.29,2.03,;-2.53,.67,;-2.54,-.87,;-1.21,-1.65,;.12,-.88,;1.45,-1.65,;1.44,-3.2,;.09,-3.96,;-1.23,-3.18,;2.77,-3.97,;2.76,-5.51,;4.11,-3.21,;5.44,-3.99,;6.78,-3.23,;8.24,-3.69,;9.14,-2.44,;8.23,-1.2,;6.77,-1.68,;-1.2,1.43,;-1.2,2.97,;.15,3.73,;1.47,2.95,;1.46,1.41,;.12,.65,;2.82,3.71,;4.14,4.49,;3.59,2.37,;2.05,5.04,)| | ||
Structure |